Investigation of the Systemic Immune Inflammation (SII) Index as an Indicator of Morbidity and Mortality in Type 2 Diabetic Retinopathy Patients in a 4-Year Follow-Up Period

被引:1
|
作者
Tabakoglu, Nilgun Tan [1 ]
Celik, Mehmet [2 ]
机构
[1] Trakya Univ, Fac Med Hosp, Hlth Res & Dev Ctr, TR-22100 Edirne, Turkiye
[2] Trakya Univ, Fac Med, Dept Endocrine & Metab Dis, TR-22100 Edirne, Turkiye
来源
MEDICINA-LITHUANIA | 2024年 / 60卷 / 06期
关键词
systemic immune inflammation; diabetic retinopathy; type 2 diabetes mellitus; microvascular complications; macrovascular complications; CARDIOVASCULAR-DISEASE RISK; ASSOCIATION;
D O I
10.3390/medicina60060855
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and Objectives: This study aimed to investigate the relationship between the systemic immune inflammation (SII) index and the development of micro and macro complications and mortality within the first year and the following three years in type 2 diabetic retinopathy patients. Materials and Methods: The retrospective study included 523 type 2 diabetic retinopathy patients seen in the endocrinology outpatient clinic of our hospital between January and December 2019. Their demographic and clinical characteristics were analyzed using descriptive statistics. The normal distribution of quantitative data was assessed by the Shapiro-Wilk test. Mann-Whitney U, McNemar-Chi-square, and Cochran's Q tests were used to analyze the SII values and complication rates over time. An ROC analysis determined the sensitivity and specificity of SII. A multiple linear regression analysis examined the relationship between variables and SII, while Spearman's test assessed the correlation between CRP and SII. p < 0.05 was accepted as significant. Results: The mean age of patients was 63.5 +/- 9.3 years, with mean SII values of 821.4 +/- 1010.8. Higher SII values were significantly associated with acute-chronic renal failure, peripheral arterial disease, and hospitalization rates in both the first year and the following three years (p < 0.05 for all). Significant cut-off values for SII were found for micro- and macrovascular complications and death within the first year (p < 0.05 for all). The ROC curve analysis identified an optimal SII cut-off value of >594.0 for predicting near-term (1-year) complications and mortality, with a sensitivity of 73.8% and specificity of 49.4% (area under the ROC curve: 0.629, p = 0.001). Multiple linear regression indicated that smoking of at least 20 pack-years had a significant positive effect on SII. The Spearman test showed a weak positive correlation between SII and CRP. Conclusions: High SII values predict both early and late acute-chronic renal failure, peripheral arterial disease, and hospitalizations in patients with type 2 diabetic retinopathy. The study also shows that high SII values may predict microvascular and macrovascular complications of type 2 DM and mortality risk in the early period in patients with type 2 diabetic retinopathy. In addition, comorbidities and inflammatory habits, such as long-term smoking, should be considered in the clinical use of SII.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Effects of delay in visiting a specialist doctor in type 2 diabetic patients on glycemic control: a retrospective cohort study with a 4-year follow-up
    Ghanbari-Jahromi, Mohadeseh
    Kharaxmi, Erfan
    Bastani, Peiand
    Shams, Mesbah
    Aryaie, Mohammad
    Bahrami, Mohammad Amin
    FAMILY MEDICINE AND PRIMARY CARE REVIEW, 2023, 25 (04): : 393 - 398
  • [22] Association of systemic immune-inflammation index (SII) and aggregate index of systemic inflammation (AISI) with thyroid nodules in patients with type 2 diabetes mellitus: a retrospective study
    Cao, Can
    Li, Chunyao
    Li, Xiaoting
    Sun, Weiwei
    Wang, Yaoxian
    BMC ENDOCRINE DISORDERS, 2023, 23 (01)
  • [23] Association of systemic immune-inflammation index (SII) and aggregate index of systemic inflammation (AISI) with thyroid nodules in patients with type 2 diabetes mellitus: a retrospective study
    Can Cao
    Chunyao Li
    Xiaoting Li
    Weiwei Sun
    Yaoxian Wang
    BMC Endocrine Disorders, 23
  • [24] The Look AHEAD Trial: Bone Loss at 4-Year Follow-up in Type 2 Diabetes
    Lipkin, Edward W.
    Schwartz, Ann V.
    Anderson, Andrea M.
    Davis, Cralen
    Johnson, Karen C.
    Gregg, Edward W.
    Bray, George A.
    Berkowitz, Robert
    Peters, Anne L.
    Hodges, Amelia
    Lewis, Cora
    Kahn, Steven E.
    DIABETES CARE, 2014, 37 (10) : 2822 - 2829
  • [25] Mortality and cardiovascular morbidity in Type 1 diabetic patients with nephropathy - 10 years prospective follow-up study
    Astrup, AS
    Tarnow, L
    Pietraszek, L
    Parving, HH
    DIABETOLOGIA, 2004, 47 : A62 - A62
  • [26] Monitoring COPD patients: systemic and bronchial eosinophilic inflammation in a 2-year follow-up
    Pignatti, Patrizia
    Visca, Dina
    Zappa, Martina
    Zampogna, Elisabetta
    Saderi, Laura
    Sotgiu, Giovanni
    Centis, Rosella
    Migliori, Giovanni Battista
    Spanevello, Antonio
    BMC PULMONARY MEDICINE, 2024, 24 (01):
  • [27] Association of Systemic Immune-Inflammation Index and Systemic Inflammation Response Index with Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus
    Liu, Wenli
    Zheng, Shuran
    Du, Xiaogang
    DIABETES METABOLIC SYNDROME AND OBESITY, 2024, 17 : 517 - 531
  • [28] Lipoprotein (a) Predicts Development of Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus: A Ten-Year Follow-up Study
    Yun, Jae-Seung
    Song, Ki-Ho
    Cha, Seon-Ah
    Lim, Tae-Seok
    Choi, Jin-A
    Jee, Donghyun
    Cha, Bong-Yun
    Ahn, Yu-Bae
    Ko, Seung-Hyun
    DIABETES, 2015, 64 : A169 - A170
  • [29] The impact of patients' involvement in cooking on their mortality and morbidity: A 19-year follow-up of patients diagnosed with type 2 diabetes mellitus
    Jandorf, Sofie
    Siersma, Volkert
    Koster-Rasmussen, Rasmus
    Olivarius, Niels De Fine
    Waldorff, Frans Boch
    SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE, 2015, 33 (01) : 33 - 39
  • [30] The incidence of nephropathy in type I diabetic patients with proliferative retinopathy:: a 10-year follow-up study
    Lövestam-Adrian, M
    Agardh, E
    Agardh, CD
    DIABETES RESEARCH AND CLINICAL PRACTICE, 1998, 39 (01) : 11 - 17